BCN Plc - Company Review
BCN Plc - Company ReviewSummary
BCN Plc (BCN), formerly Boots Company Nig. Limited is a healthcare company that manufactures and markets generic products. The company offers generic products which include pharmaceuticals, agro veterinary, cosmetics and toiletry products. Its products comprise beecodeen tablets, beekolin expectorant, beekolin expectorant with codine, beekolin peadiatric, calamine lotion, nerve and bone, febrilix syrup, ivax suspension, kidiquine plus, penetrol inhalant, and PR tablets. BCN also offers paracetamol tablets, pain reliever tablets, febrilix elixer, penetrol inhalant, and ivax suspension. The company offers products in the form of tablets, syrups, suspension, inhalant and lotions. It markets products across Nigeria. BCN is headquartered in Ikeja, Nigeria.
This comprehensive company report of BCN Plc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.